Distribution of spreading viruses during COVID-19 pandemic: Effect of mitigation strategies

Autor: Elif Kıymet, Tanju Çelik, Yüce Ayhan, Yaşar Tamer Alp, Kamile Ötiken Arıkan, Tuğçe Aydın, Miray Yılmaz Çelebi, Şahika Şahinkaya, Mine Düzgöl, A. Kara, İlker Devrim, Murat Muhtar Yılmazer, Rana İşgüder, Elif Böncüoğlu, Gamze Gülfidan, Ela Cem, Nuri Bayram, Arzu Bayram
Rok vydání: 2021
Předmět:
Zdroj: American Journal of Infection Control
ISSN: 0196-6553
DOI: 10.1016/j.ajic.2021.06.002
Popis: Background: The study aimed to evaluate the distribution of circulating respiratory viral pathogens other than severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during the first year of the coronavirus disease-2019 (COVID-19) pandemic with especially focusing on the effects of the national-based mitigation strategies. Methods: This single-center study was conducted between March 11, 2020-March 11, 2021. All children who were tested by polymerase chain reaction on nasopharyngeal swabs for SARS-CoV-2 and other common respiratory viral pathogens were included in the study. Results: A total of 995 children with suspected COVID-19 admitted to the study center. Of these, 513 patients who were tested by polymerase chain reaction for both SARS-CoV-2 and common respiratory viral pathogens were included in the final analysis. Two hundred ninety-five patients were (57.5%) male. The median age was 3 years of age (27 days-17 years). A total of 321 viral pathogens identified in 310 (n: 310/513, 60.4%) patients, and 11 of them (n: 11/310, 3.5%) had co-detection with more than 1 virus. The most common detected virus was rhinovirus (n: 156/513, 30.4%), and SARS-CoV-2 (n: 122/513, 23.8%) followed by respiratory syncytial virus (n: 18/513, 3.5%). The influenza virus was detected in 2 patients (0.4%). A total of 193 patients were negative for both SARS-CoV-2 and other pathogens. Conclusions: There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic. (c) 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Databáze: OpenAIRE